Abstract:The title compound (2S,3S,E)-4-(3,4-dihydroxybenzylidene)-3-(3,4-dihydroxy-phenyl)-5-oxotetrahydrofuran-2-carboxylic acid was synthesized and the 2D structure was characterized by H-1-NMR C-13-NMR and LCMS. The absolute configuration was determined by single-crystal X-ray diffraction of the key intermediate (2S,3S,E)-ethyl 4-(3,4-dimethoxybenzylidene)- 3-(3,4-dimethoxyphenyl)-5-oxotetrahydrofuran-2-carboxylate. The crystal belongs to tetragonal system, space group P4(1) with a = 13.0665(2), b = 13.0665(2), c = 13.4735(2) angstrom, V = 2300.4(6) angstrom(3), Z = 4, D-c = 1.278 g/cm(3), mu(CuK alpha) = 0.801 mm(-1), F(000) = 936, S = 1.050, R = 0.0364 and wR (I > 2 sigma(I)) = 0.1071. X-ray diffraction results showed that the molecular structure is stabilized totally by Van der Waals force. The antibacterial activity tests showed that the title compound possesses slight synergistic effect against MRSA and Acinetobacter baumanii.

Synthesis and Characterization of (4R,5r)-1,3-dioxolance-4,5-bis(2-pyridineacrboxylic Acid)

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

3,5-Bis[(pyridin-4-yl)methoxy]benzoic acid

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Synthesis and Crystal Structure of 4, 5-Diazafluorene-9-one Azine Hydrochloride Hydrate

Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

Synthesis And Crystal Structure Of 4-Bromo-5-Ethoxy-3-Methyl-5-(Naphthalen-1-Yl)-L-Tosyl-1h-Pyrrol-2(5h)-On E

Synthesis and Crystal Structure of 3-N-acetyl-5-(pyridin-3-yl)-2-(quinolin-2-yl)-1,3,4-oxadiazoline, C18H14N4O2

(E)-Dimethyl 4-(Ethylamino)-5-styrylfuran-2,3-dicarboxylate

Acid-induced Atypical Spontaneous Conversion of 5-Amino-2,6-dioxooctahydro-1h-pyrrolo[2,1-d][1,5]oxazocine into 4-(Hydroxymethyl)-2,5-dioxooctahydro-1h-pyrrolo[1,2-d][1,4]diazepine

Synthesis and Crystal Structure of 1-(1′,3′-Dimethyl-5′-chloropyrazol-4′-carbonyl′-3-(2′-chlorophenyl)-5-amino-4-cyanopyrazole

(E)-Dimethyl 4-butylamino-5-(4-methylstyryl)-furan-2,3-dicarboxylate

Synthesis and Structure of Ethyl 3-Acetamido-4-aryl-6-methyl-2-oxo-3,4-dihydropyran-5-carboxylates

Synthesis and Crystal Structure of Ethyl 5-Acetamido-4-(4-chlorophenyl)-2-methyl-6-oxo-5,6-dihydro-4 H-pyran-3-carboxylate

Synthesis And Crystal Structure Of 7-Acetamido-5-Chloro-8-(P-Methyloxybenzenesulfonyloxy)-2-Styrylquinoline

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Synthesis and crystal structure of 3-(2,4-dichlorophenyl)-4-dydroxy-5- cyclohexanyl-Δ3-dihydrofuran-2-one

Synthesis And Crystal Structure Of Triethyl 1,2,2-Triphenylpyrrolidine-3,4,5-Tricarboxylate, A Proline Derivative

Synthesis and crystal structure of 3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-(methylsulfonyl)benzoic acid, C 12 H 13 NO 5 S

(1 R ,2 S ,5 R )-2-Isopropyl-5-methylcyclohexyl (2 S ,3 S )-3-phenyloxirane-2-carboxylate

Synthesis And Crystal Structure Of 5-(3,4-Dimethoxyphenyl)-1-Phenyl-3-Hydroxypyrazole